Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
09915671 ยท 2018-03-13
Assignee
Inventors
Cpc classification
B01L2300/0636
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0627
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/10
PERFORMING OPERATIONS; TRANSPORTING
G01N11/00
PHYSICS
B01L3/502
PERFORMING OPERATIONS; TRANSPORTING
G01N33/86
PHYSICS
B01L2400/0475
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0861
PERFORMING OPERATIONS; TRANSPORTING
B01L3/52
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/087
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N33/86
PHYSICS
B01L3/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
The present invention is directed to a cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, in particular a blood sample, comprising a cartridge body having at least one measurement cavity formed therein and having at least one probe element arranged in said at least one measurement cavity for performing a test on said sample liquid; and a cover being attachable on said cartridge body; wherein said cover covers at least partially said at least one measurement cavity and forms a retaining element for retaining said probe element in a predetermined position within said at least one measurement cavity. The invention is directed to a measurement system and a method for measuring viscoelastic characteristics of a sample liquid.
Claims
1. A device for evaluation of hemostasis, comprising: a plurality of cavities, including a first cavity, a second cavity and a third cavity, wherein each of the plurality of cavities comprises one or more reagents therein; ductwork, including an inlet for receiving a test sample, wherein the ductwork is in communication with each of the plurality of cavities, whereby each of the plurality of cavities is configured to receive, via the ductwork, a portion of the test sample, wherein the first cavity comprises one or more reagents configured for extrinsic activation of the coagulation cascade; wherein the second cavity comprises (i) one or more reagents configured for extrinsic activation of the coagulation cascade and (ii) one or more reagents configured for suppressing thrombocyte function; and wherein the third cavity comprises one or more reagents configured for intrinsic activation of the coagulation cascade.
2. The device of claim 1, wherein the one or more reagents configured for suppressing thrombocyte function include cytochalasin D.
3. The device of claim 1, wherein the one or more reagents configured for extrinsic activation of the coagulation cascade include tissue factor.
4. The device of claim 3, wherein the one or more reagents configured for suppressing thrombocyte function include cytochalasin D.
5. The device of claim 1, wherein the one or more reagents configured for intrinsic activation of the coagulation cascade include a Hagemann factor.
6. The device of claim 1, wherein the plurality of cavities further comprises a fourth cavity.
7. The device of claim 6, wherein the fourth cavity comprises one or more reagents configured for testing platelet aggregometry.
8. The device of claim 1, wherein the device is a cartridge configured for use in conjunction with a measuring system.
9. The device of claim 8, wherein the measuring system is configured to measure over time changes in viscoelastic properties of the portion of the test sample in each of the cavities.
10. The device of claim 9, wherein the measuring system is configured to receive the cartridge in a pre-determined orientation whereby the cartridge in the pre-determined orientation is aligned with a plurality of detectors, each of the plurality of detectors associated with a respective cavity.
11. The device of claim 9, wherein the changes in viscoelastic properties of the portion of the test sample are measured by the measuring system detecting changes in amplitude of an oscillating motion excitation of the portion of the test sample.
12. The device of claim 11, wherein the oscillating motion excitation of the portion of the test sample is achieved mechanically via a plurality of probes interfaced with the measuring system.
13. The device of claim 9, wherein the measuring system is configured to measure clotting time for the portion of the test sample in each of the cavities.
14. The device of claim 9, wherein the measuring system is configured to measure clot formation time for the portion of the test sample in each of the cavities.
15. The device of claim 9, wherein the measuring system is configured to measure a maximum clot firmness for the portion of the test sample in each of the cavities.
16. The device of claim 9 wherein the measuring system includes a light beam detector.
17. The device of claim 16, wherein the light beam detector is used to detect changes in amplitude of an oscillating motion excitation of the portion of the test sample.
18. The device of claim 9, wherein the measurement system is configured to measure changes in viscoelastic properties of the portions of the test samples based on a periodic induced motion in the portions of the test sample.
19. The device of claim 18, wherein the periodic induced motion is a periodic rotational motion by a shaft.
20. A method for using the device of claim 9, the method comprising measuring over time changes in viscoelastic properties of the portion of the test sample in each of the cavities and comparing the measured changes in viscoelastic properties of the portion of the test sample in the first chamber with the measured changes in viscoelastic properties of the portion of the test sample in the second chamber.
21. The method of claim 20, further comprising assessing a fibrinogen deficiency on the basis of the comparison.
22. A method for using the device of claim 9, the method comprising measuring over time changes in viscoelastic properties of the portion of the test sample in each of the cavities and assessing a fibrinogen deficiency on the basis of such measurements.
23. A method for using the device of claim 9, the method comprising performing at least three measurements in parallel within the plurality of cavities using a combination of agonists and antagonists of different parts of the coagulation cascade.
24. The device of claim 8, wherein the measuring system includes control apparatus configured for interacting with the cartridge to move the test sample through the cartridge.
25. The device of claim 8, wherein the measuring system includes control apparatus for measurement, data analysis and user interaction.
26. The device of claim 8, wherein the measuring system is configured for receiving and securing the cartridge.
27. The device of claim 1, wherein the one or more reagents within each of the plurality of cavities are in a solid form.
28. The device of claim 1, wherein each of the plurality of cavities is a measurement cavity integrally formed with a reagent cavity.
29. The device of claim 28, wherein each measurement cavity is configured for measuring viscoelastic characteristics of the portion of the test sample.
30. The device of claim 1, further comprising a housing.
31. The device of claim 30, wherein the housing defines the inlet.
32. The device of claim 30, wherein each of the plurality of cavities are at least partially defined by the housing.
33. The device of claim 30, wherein the housing includes a housing body and a cover, wherein the housing body and the cover cooperate to define and enclose the ductwork and cavities.
34. The device of claim 30, wherein the housing defines a unitary cartridge comprising the plurality of cavities and the ductwork.
35. The device of claim 34, wherein the cartridge is disposable.
36. The device of claim 1, wherein the device is configured for measuring viscoelastic characteristics of each of the portion of the test sample based on detecting changes in clot firmness.
37. The device of claim 36, wherein clot firmness is continuously determined from formation of fibrin fibres through dissolution by fibrinolysis.
38. The device of claim 1, wherein the device is configured for performing at least three measurements in parallel within the plurality of cavities using a combination of agonists and antagonists of different parts of the coagulation cascade.
39. The device of claim 1, wherein the device is configured such that the one or more reagents within each of the cavities are mixed with the portion test sample in a portion of the fluid pathway prior to being delivered to the cavities.
40. A method for using the device of claim 1, comprising mixing the one or more reagents in each of the cavities with the portion test sample in a portion of the fluid pathway prior to being delivered to the cavities.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The figures are showing the following:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
DESCRIPTION OF EXEMPLARY EMBODIMENTS
(26) Parts and components having same functions are depicted with same references.
(27) Prior to a detailed description of the preferred embodiments the basic features and a basic practical implementation are summoned as follows. All embodiments refer to a cartridge device 50 (see
(28) A first embodiment of a cartridge device 50 of the invention will be described with reference to
(29) In this embodiment the receiving cavity 16 consists of a cavity within the cartridge device 50. The sample liquid 1 can be applied by means of a syringe, pipette etc, e.g. through a self sealing cap shown as a receiving cavity cover 33a in
(30) In an alternative embodiment the reagent cavity 19 is integral formed with the pump means 18 and/or with the measurement cavity 20 and/or with the ductwork. The transport of the sample liquid 1 can be controlled by said control apparatus.
(31)
(32) In a preferred embodiment the cartridge device 50 comprises four arrangements of
(33) Regarding e.g. blood coagulation there are different reagents available which activate or suppress different parts of the coagulation cascade. Pentapharm GmbH (Munich, Germany) for example amongst others provide tests for intrinsic and extrinsic activation of a blood sample (INTEM or EXTEM respectively), and also a test for extrinsic activation in which the thrombocyte function is suppressed by administration of cytochalasin D (FIBTEM). It is state of the art that it is possible by wise combination of such tests to be able to determine very precisely at which point within the coagulation cascade a problem occurs. This is of great importance in order to determine a proper medication. By comparison of the results on an EXTEM test of a pathologic sample to those of a FIBTEM test of the same sample it is possible to e.g. precisely determine if a coagulation disorder results from lack of fibrinogen or a malfunction of platelets. Generally, there are different typical medical scenarios in which coagulation disorders are very likely to occur. For example coagulation disorders occurring during liver transplantation are merely caused by lack of certain coagulation factors etc., while coagulation disorders during open heart surgery are most likely due to the influence of heparin. This means basically that different medical settings require different coagulation tests. Referring to
(34) It is important to note that the cartridge devices 50 of the described embodiments are suitable for different diagnostic tests like thromboelastometry, thromboelastography, platelet aggregometry and others. Depending on which type of test or tests the cartridge device 50 is designed for, there are different additional parts required which interact with the sample during measurement and/or an external control apparatus. Possible adaptations for thromboelastometry and platelet aggregometry are described below.
(35)
(36) The probe element 22 comprises the probe pin 3 (see
(37) The probe element 22 is arranged in the measurement cavity 20 of the cartridge body 30 of the cartridge device 50 as shown in
(38) During attaching the cartridge device 50 to the measuring system 40 (see also
(39) It is also possible to insert the insert section 6a of the shaft 6 into the connector section 26 of the probe element 22 and push the probe element 22 down until its bottom contacts the bottom of the measurement cavity 20, 20 ensuring that the insert section 6a is completely inserted into the connector section 26. Then the shaft 6 will be moved up into the measuring resp. working position of the probe element 22 as shown in
(40)
(41) Now a third embodiment of the cartridge device 50 will be described with reference to
(42)
(43) The cartridge device 50 of this example is equipped with the ductwork 13 and 15. The ducts are formed with an diameter of approximately 1 mm in this embodiment. The ductwork requires that the cartridge device 50 comprises two parts: the cartridge body 30 and the cover 31, which are glued or welded together to obtain a leak-proof device. The cartridge body 30 is relative rigid and the cover 31 is formed as an elastic part. So it is possible to integrate the pump means 18 into the cover 31. Moreover, the cover 31 covers the receiving cavity 16 with the receiving cavity cover 33a and forms a type of liner wall 33 and a separation wall 34 forming an inlet for the inlet duct 13 within the receiving cavity 16. The receiving cavity cover 33a might act as a self seal for injection of a sample liquid 1 by a syringe for example. The cover 31 forms top parts of the ductwork 13 an 15 and a cover of the measurement cavity 20 (see also
(44) In this embodiment a reagent cavity 19, 19 is formed, e.g. by sections of the ductwork or/and the pump means 18, 18 in which the reagents can be stored resp. deposited, especially on the pump cavity bottom 36a, for example.
(45) The pump means 18 will now be described with reference to
(46)
(47) In this example the pump cavity 36 is connected to the inlet duct 13 via an inlet valve 37 and to the outlet valve via an outlet valve 38. Actuation of the pump membrane 35 (shown in
(48) An external force exerted on the pump membrane 35 increase the pressure within the pump cavity 36 and opens outlet valve 38 and doses inlet valve 37. Releasing the external force the elastic pump membrane 35 returns into the position shown in
(49) Now the measuring system 40 according to the invention is described in an embodiment with reference to
(50)
(51) The measuring system 40 comprises an interface element 41 to which the cartridge device 50 is attached and fixed. The interface element 41 is shown in
(52)
(53) Thus it is possible to e.g. arrange a reagent receptacle 19b in a blister receptacle e.g. as shown in
(54) It is also possible to insert reagent receptacles into provided cavities being connected to the ductwork. The reagents can be designed as globules with an appropriate diameter so that they cannot flow through openings into the ductwork before being dissolved by the sample liquid.
(55)
LIST OF REFERENCE NUMERALS
(56) 1 Sample liquid 2 Cup 3 Probe pin 4 Torsion wire 5 Rotation axis 6 Shaft 6a Insert section 7 Bearing 8 Mirror 9 Spring 10 Detecting means 11 Base plate 12 Cup holder 13, 13 Inlet duct 14, 14 Intermediate duct 15, 15 Outlet duct 16, 16 Receiving cavity 17 Branch duct 18, 18 Pump means 19,19 Reagent cavity 19a, 19a Regents cavity bottom 19b Reagent receptacle 20, 20 Measurement cavity 21, 21 Reagent 22, 22 Probe element 23 Intermediate section 24 Flange 25 Fixing section 26 Connector section 27 Insertion guide 28 Groove 29 Dimple 29a Nose 30 Cartridge body 31 Cover 32 Fixing means 32a Opening 33 Wall 33a Receiving cavity cover 34 Separation wall 35 Pump membrane 36 Pump cavity 36a Pump cavity bottom 37 Inlet valve 38 Outlet valve 39 Flow direction 40 Measuring system 41 Interface element 42 Pump access 43 inlet opening 44 Shaft passage 44a Passage hole 45 Reagent cover opening 46 Retaining ring 47 Frame 48 Bottom foil 49 Blister cover 50 Cartridge device